骶神经调节技术在排尿功能障碍治疗中的应用与进展

doi:10.6040/j.issn.1671-7554.0.2018.101

摘要/Abstract

摘要： 骶神经调节(SNM)技术是一种通过人工植入的“起搏器”发出短脉冲刺激电流信号连续作用特定的骶神经,以调节膀胱、尿道括约肌及盆底等骶神经支配的下游效应器官的微创技术。SNM技术分体验阶段与长期刺激器植入阶段,疗效可靠,操作简便易学,在难治性膀胱功能障碍中有着广阔的应用前景。对于患者来说,SNM技术具有微创有效、疗效持久及耐受性佳等优点,深受顽固性排尿功能障碍患者的青睐。简述SNM技术的作用原理及优势,总结近年SNM技术在排尿功能障碍治疗领域的应用,分析其未来的发展方向及应用前景。

关键词: 骶神经调节, 排尿功能障碍, 应用, 进展

Abstract: Sacral neuromodulation(SNM)is one of minimally invasive techniques for regulating downstream target organs, such as bladder, urethral sphincter and pelvic floor muscle. Pulsatile stimulating is carried out on sacral nerve through a manually implanted “pacemaker” in SNM. For surgeons, SNM technology is divided into two phases: the 山东大学学报 (医学版)56卷3期 -徐智慧,等.骶神经调节技术在排尿功能障碍治疗中的应用与进展 \=-experience phase and the long-term stimulator implantation phase with the advantages of simple operation, easy learning and reliable effect, and has a broad promotional prospect for refractory bladder dysfunction. For patients, SNM technology has the advantages of safety and efficiency, little damage, good long-term tolerance, long effective duration, and has broad application prospects in the supplement and adjuvant therapy of refractory bladder dysfunction. This article introduces the principle and advantages of SNM, which focuses on the application in bladder dysfunction treatment, and analyzes the direction and the broad prospect of SNM.

Key words: Sacral neuromodulation, Bladder dysfunction, Application, Progress

中图分类号:

R694

徐智慧,魏海彬. 骶神经调节技术在排尿功能障碍治疗中的应用与进展[J]. 山东大学学报 (医学版), 2018, 56(3): 29-33.

XU Zhihui, WEI Haibin. Application and progress of sacral neuromodulation in bladder dysfunction[J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 29-33.

参考文献

[1] 张德清,朱耀丰,孟辉,等.膀胱内灌注透明质酸钠治疗非细菌性膀胱炎的临床观察[J].山东大学学报(医学版), 2013, 51(1): 79-82. ZHANG Deqing, ZHU Yaofeng, MENG Hui, et al. Clinical observation on intravesical instillation of sodium hyaluronate for treatment of non-bacterial cystitis[J]. Journal of Shandong University(Health Science), 2013, 51(1): 79-82.
[2] Madersbacher H. Conservative therapy of neurogenic disorders of micturition[J]. Urologe A, 1999, 38(1): 24-29.
[3] Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future[J]. Urology, 1982, 20(6): 614-619.
[4] Tanagho EA. Neural stimulation for bladder control[J]. Semin Neurol, 1988, 8(2): 170-173.
[5] 卫中庆.排尿功能障碍治疗的新亮点——骶神经调节(排尿起博器)治疗技术[J]. 中华医学信息导报, 2005, 20(13): 15.
[6] Schmidt RA. Applications of neurostimulation in urology[J]. Neurourology and Urodynamics, 1988, 7(6): 585-592.
[7] Steele SS. Sacral nerve stimulation: 50 years in the making[J]. Can UrolAssoc J, 2012, 6(4): 231-232.
[8] 陈国庆, 廖利民. 骶神经调节在神经源性膀胱中的应用[J]. 临床外科杂志, 2016, 24(2): 102-104.
[9] Simpson JA, Peacock J, Maxwell-Armstrong C. Use of a gentamicin-impregnated collagen sheet(Collatamp(^®))following implantation of a sacral nerve stimulator for faecal incontinence[J]. Colorectal Dis, 2012, 14(4): e200-e202. doi: 10.1111/j.1463-1318.2011.02886.x.
[10] Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention[J]. Urology, 2000, 56(6): 87-91.
[11] van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study[J]. J Urol, 2007, 178(5): 2029-2034.
[12] Hoda MR, Fornara P. Sacral neuromodulation in urology. The emperors new clothes or effective high-tech medicine?[J]. Urologe A, 2010, 49(10): 1254-1259.
[13] 李延伟,李一冬,文建国.骶神经调节治疗非梗阻性尿潴留的研究进展[J].中华临床医师杂志(电子版), 2016, 10(23): 3598-3601. LI Yanwei, LI Yidong, WEN Jianguo. Advances in sacral neuromodulation for the treatment of nonobstruction urinary retention[J]. Chin J Clinicians(Electronic Edition), 2016, 10(23): 3598-3601.
[14] Cardarelli S, DElia C, Cerruto MA, et al. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project[J]. Urologia, 2012, 79(2): 90-96.
[15] Dyer AJ, Twiss CO. Painful bladder syndrome: an update and review of current management strategies[J]. Curr Urol Rep, 2014, 15(2): 384.
[16] Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerativeinterstitial cystitis[J]. Urol Int, 1996, 56(3): 137-162.
[17] Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis[J]. Urology, 2007, 69(4): 24-33.
[18] 张鹏,吴栗洋.骶神经调节治疗慢性间质性膀胱炎/盆腔疼痛综合征[J].现代泌尿外科杂志, 2016, 21(8): 573-576. ZHANG Peng, WU Liyang. Treating chronic interstitial cystitis/pelvic pain syndrome with sacral neuromodulation[J]. Journal of Modern Urology, 2016, 21(8): 573-576.
[19] Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures[J]. J Urol, 2010, 183(1): 173-176.
[20] Gajewski JB, Alzahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre[J]. BJU Int, 2011, 107(8): 1258-1264.
[21] Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis[J]. Eur Urol, 2010, 58(6): 865-874.
[22] Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease[J]. Spinal Cord, 2014. doi: 10.1038/sc.2014.157.
[23] 徐智慧,吕佳,王帅,等.骶神经调节治疗慢性非梗阻性尿潴留的临床观察[C].浙江省泌尿外科学男科学学术年会, 2015.
[24] Lombardi G, Nelli F, Mencarini M, et al. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury[J]. Spinal Cord, 2011, 49(5): 629-636.
[25] 顾寅珺,吕婷婷,方伟林,等.3D打印技术在骶神经调控术中精准穿刺的应用评估研究[J].临床泌尿外科杂志, 2016, 31(12): 1057-1059. GU Yinjun, LÜ Tingting, FANG Weilin, et al. 3D printing in the evaluation of sacral neuromodulation[J]. Journal of Modern Urology, 2016, 31(12): 1057-1059.
[26] Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis[J]. World J Urol, 2012, 30(1): 123-128.

相关文章 15

[1]	机器人辅助经椎间孔腰椎椎体间融合术手术技术专家组. 机器人辅助经椎间孔腰椎椎体间融合术专家共识[J]. 山东大学学报 (医学版), 2026, 64(2): 11-21.
[2]	崔倩倩,李金鹏,吴豫丹,侯志平,孙玮螺,崔盼盼,何培元. 粪便miRNA对结直肠进展期腺瘤无创筛查的临床价值[J]. 山东大学学报 (医学版), 2025, 63(2): 43-50.
[3]	郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83.
[4]	林晓倩,封茂燕,牟正. 二肽基肽酶-4抑制剂的药学特点及临床应用[J]. 山东大学学报 (医学版), 2024, 62(12): 43-48.
[5]	司海朋,王崇怡,宫桂青,张文灿,郭英俊,王凯斌,冯运泽,徐万龙,李乐. 加速康复外科在脊柱外科中的应用进展[J]. 山东大学学报 (医学版), 2024, 62(10): 8-17.
[6]	张杨,李晓旭. 加速康复外科理念在骨折治疗中的研究进展[J]. 山东大学学报 (医学版), 2024, 62(10): 18-25.
[7]	唐宁,黄晓莉,宋桂花. 老年髋部骨折手术患者营养管理研究进展[J]. 山东大学学报 (医学版), 2024, 62(10): 42-47.
[8]	张建树,张瀚文,赵文静. 长链非编码RNA ZNF528-AS1促进乳腺癌他莫昔芬耐药及进展转移[J]. 山东大学学报 (医学版), 2023, 61(1): 17-26.
[9]	马翔,赵飞燕. 。卵子冷冻保存现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 19-23.
[10]	王颖,顾慧,于鑫鑫,胡锦卓,王箬芃,王锡明. 71例腹主动脉瘤的基线CT特征与病变进展的相关性[J]. 山东大学学报 (医学版), 2022, 60(10): 62-67.
[11]	王传新. 肿瘤液体活检[J]. 山东大学学报 (医学版), 2021, 59(9): 64-71.
[12]	王沂峰,何丽清. 外阴癌腹股沟淋巴结手术的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 103-109.
[13]	史本康,陈守臻,曲思凤,王勇,刘磊. 临床常见快速进展前列腺癌临床特点及研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 110-116.
[14]	孙庆杰,张怡莎,管尚慧,凤志慧. 丙戊酸对134例放疗神经胶质瘤患者预后生存和肿瘤复发的影响[J]. 山东大学学报 (医学版), 2021, 59(8): 80-85.
[15]	黄蕾,叶子雯,李湉湉. 环境健康风险感知研究进展[J]. 山东大学学报 (医学版), 2021, 59(12): 6-12.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed